Humedix's 'Liztuo' Sales Grow Fivefold, Offsetting Weak Fillers [Why Bio]
Predicted impact: Medium
Liztuo sales up fivefold offsetting weak fillers; meaningful for revenue mix.
Humedix휴메딕스
200670 · KOSDAQ · ₩200670 · 휴메딕스
₩23,700▲ ₩750 (3.27%)End-of-day · Oct 28, 2026 · End-of-day prices.
Humedix extends distribution contract for filler 'Elavie' with China's Beijing Jingjing
Predicted impact: Low
China filler distribution extension already reported in the last 14 days; small.
Humedix Strengthens Push into China's Filler Market, Extends Local Distribution Contract
Predicted impact: Low
Distribution contract extension in China; no size disclosed and likely small versus revenue.
Humedix Extends Exclusive Distribution Partnership with Beijing Jingjing for 'Elravie' Filler in China
Predicted impact: Low
Distribution partnership extension in China; no contract size disclosed.
[Today's IR] Unid, Humedix, Kyungdong City Gas and others
Predicted impact: Low
Routine IR event listing; no material news.
Also known as: Humedix / 휴메딕스 / 200670 / KRX:200670
Source: KRX statistical information